Gastric cancer is the second leading cause of cancer mortality worldwide. The major cause of treatment failure for gastric cancer is the development of multidrug resistance (MDR) to chemotherapy, which is currently one of the primary treatment options. Recently, research into the MDR of gastric cancer has revealed that, in addition to the classical ATP-binding cassette transporters, such as P-glycoprotein (P-gp) and MDR-associated protein (MRP)1, a number of other molecules might mediate the drug resistance of human gastric cancer. The absence of P-gp and MRP1 expression in some gastric cancer cases also indicates that there might be other mechanisms responsible for human gastric cancer MDR. These molecules belong to different functional families and might work together to confer MDR phenotypes. The new findings may provide new clues to the mechanisms of MDR and enable the selection of new candidates for targeting MDR in human gastric cancer.
Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Publishing Authors By Initials
Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Journal Published:
PUBLICATION TYPE: Review
Journal: Expert review of anticancer therapy
VOLUME: 7
Page Numbers: 1369-78
Journal Abbreviation: Expert Rev Anticancer Ther
ISSN: 1744-8328
DAY: 5
MONTH: Oct
YEAR: 2007
Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Information
Number of References: 81
LANGUAGE: eng
NlmUniqueID: 101123358
Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.
AFFILIATION: Institute of Digestive Disease & State Key Laboratory of Cancer Biology, Xjing Hospital, The Fourth Military Medical University, 15 West Chang-Le Road, Xi'an, Shaanxi 710032, PR China. dx66@163.com
Country: England
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Expert Rev Anticancer Ther
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges Related Publications